文献速递骨质疏松与代谢性骨病小儿骨科

唐氏综合征患者骨密度变化的系统评价与荟萃分析

Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2021-08-12

该系统评价与荟萃分析检索截至2021年1月1日的文献,纳入15项研究,比较唐氏综合征(DS)个体与对照的骨密度(BMD)。结果显示DS个体全身、全髋、腰椎和股骨颈BMD均显著降低;经骨骼体积校正后,腰椎体积BMD仍降低,而股骨颈体积BMD升高。

要点

  • DS个体全身、全髋、腰椎及股骨颈BMD均显著低于对照。
  • 经体积校正后,腰椎vBMD降低而股骨颈vBMD升高。
  • 临床需关注DS患者骨健康,但研究间全身BMD异质性高。

核心结论

  • 唐氏综合征个体全身及区域(全髋、腰椎、股骨颈)骨密度较一般人群降低。
  • 经骨骼体积校正后,腰椎体积骨密度仍较低,而股骨颈体积骨密度升高。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、EMBASE、Web of Science和Cochrane Library截至2021年1月1日,纳入15项研究。

主要发现

  • 全身BMD:MD=-0.18,95%CI(-0.23至-0.12),P<0.00001,I²=89%。
  • 全髋BMD:MD=-0.12,95%CI(-0.15至-0.10),P<0.00001,I²=0%。
  • 腰椎BMD:MD=-0.12,95%CI(-0.14至-0.09),P<0.00001,I²=18%。
  • 股骨颈BMD:MD=-0.08,95%CI(-0.10至-0.06),P<0.00001,I²=0%。
  • 腰椎vBMD:MD=-0.01,95%CI(-0.02至-0.01),P=0.0004,I²=19%;股骨颈vBMD:MD=0.01,95%CI(0.00至0.02),P=0.02,I²=0%。

临床怎么用

  • 对唐氏综合征患者应关注骨密度下降风险,考虑进行骨健康评估。
  • 解读股骨颈体积BMD升高需结合临床,不应单纯视为骨保护效应。

局限性

  • 全身BMD分析异质性高(I²=89%),可能影响结果稳定性。
  • 纳入研究数量有限(15项),未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data evaluating changes in bone mineral density (BMD) in Down syndrome (DS) individuals remains controversial. Therefore, we conducted a systematic review and meta-analysis to better understand associations between BMD and DS. A systematic literature search of PubMed, EMBASE, Web of Science, and the Cochrane Library up until 1st January 2021 was conducted. We used the keywords "bone mineral density" and "Down Syndrome." Fifteen studies were included. Overall, our results showed a significant decrease in BMD of total body (TB BMD) [MD = - 0.18; 95% CI (- 0.23 and - 0.12), P < 0.00001, I2 = 89%], total hip (TH BMD) [MD = - 0.12; 95% CI (- 0.15 and - 0.10), P < 0.00001, I2 = 0%], lumbar spine (LS BMD) [MD = - 0.12; 95% CI (- 0.14 and - 0.09), P < 0.00001, I2 = 18%], and femoral neck (FN BMD) [MD = - 0.08; 95% CI (- 0.10 and - 0.06), P < 0.00001, I2 = 0%] in DS individuals when compared with controls. Moreover, the volumetric BMD of lumbar spine (LS vBMD) [MD = - 0.01; 95% CI (- 0.02 and - 0.01), P = 0.0004, I2 = 19%] also showed a decreasing tendency while the volumetric BMD of the femoral neck (FN vBMD) [MD = 0.01; 95% CI (0.00 and 0.02), P = 0.02, I2 = 0%] was elevated in DS individuals versus controls. These findings demonstrated that individuals with DS had a decreased total and regional (TH, LS, and FN) BMD when compared with the general population. Additionally, when BMD was adjusted for skeletal volume, LS vBMD was also lower, while FN vBMD was elevated in DS individuals versus controls.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Tian Z, Ye S, et al. Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis. Osteoporos Int. 2021. PMID: 34383099. doi:10.1007/s00198-021-06070-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。